Market openNon-fractional

Humacyte/HUMA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Humacyte

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Ticker

HUMA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Durham, United States

Employees

184

Humacyte Metrics

BasicAdvanced
$675M
Market cap
-
P/E ratio
-$1.01
EPS
1.61
Beta
-
Dividend rate
$675M
1.61
8.371
8.199
79.378
89.771
-15.31%
-36.66%
-195.68%
25.84
25.84
-7.105
257.84%
-70.21%

What the Analysts think about Humacyte

Analyst Ratings

Majority rating from 6 analysts.
Buy

Humacyte Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$32M
26.69%
Profit margin
0.00%
NaN%

Humacyte Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 28.89%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.25
-$0.24
-$0.29
-
Expected
-$0.22
-$0.25
-$0.24
-$0.23
-$0.24
Surprise
0.15%
-1.32%
-1.98%
28.89%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Humacyte stock?

Humacyte (HUMA) has a market cap of $675M as of July 05, 2024.

What is the P/E ratio for Humacyte stock?

The price to earnings (P/E) ratio for Humacyte (HUMA) stock is 0 as of July 05, 2024.

Does Humacyte stock pay dividends?

No, Humacyte (HUMA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Humacyte dividend payment date?

Humacyte (HUMA) stock does not pay dividends to its shareholders.

What is the beta indicator for Humacyte?

Humacyte (HUMA) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Humacyte stock

Buy or sell Humacyte stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing